Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Baxter
Colorcon
Johnson and Johnson
Mallinckrodt

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

ANTIZOL Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Antizol, and what generic alternatives are available?

Antizol is a drug marketed by Par Pharm Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in ANTIZOL is fomepizole. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fomepizole profile page.

Summary for ANTIZOL
International Patents:9
US Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: 134
Clinical Trials: 1
Patent Applications: 1,025
Formulation / Manufacturing:see details
DailyMed Link:ANTIZOL at DailyMed
Drug patent expirations by year for ANTIZOL
Recent Clinical Trials for ANTIZOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of UtahPhase 1

See all ANTIZOL clinical trials

Synonyms for ANTIZOL
1H-Pyrazole, 4-methyl-
4-methyl pyrazole
4-methyl-1h_pyrazole
4-Methyl-1H-pyrazole
4-methyl-pyrazole
4-Methylpyrazol
4-Methylpyrazole
4-Methylpyrazole, 97%
4-methylpyrazole;Antizol;Antizol-Vet;Antizol
5-23-05-00031 (Beilstein Handbook Reference)
554M656
615557-09-0
7554-65-6
83LCM6L2BY
A9615
AB0018506
AB00390
AB00918526_06
AB00918526_07
AB2000244
AC-4833
AC1L1FV5
AC1Q2OK9
AC1Q2OKA
ACMC-209oys
ACN-004649
ACT05848
ACT08853
AJ-24276
AK-46480
AKOS000265586
ALBB-016317
AM20100737
AN-11585
Antizol (TN)
Antizol-vet
ANW-36626
BB 0257933
BBL015773
BC677698
BDBM50226186
BR-46480
BRN 0105204
C-5324
C07837
C4H6N2
CCG-204808
CHEBI:5141
CHEMBL1308
CJ-04506
CL3422
CTK2H7174
D00707
DB-022514
DB01213
DTXSID3040649
EC 231-445-0
EINECS 231-445-0
EN300-50246
Fomepizol
Fomepizol [INN-Spanish]
fomepizole
Fomepizole (Antizol)
Fomepizole (JAN/USAN/INN)
Fomepizole [USAN:INN:BAN]
Fomepizole [USAN:INN]
Fomepizole, 99%
Fomepizolum
Fomepizolum [INN-Latin]
FT-0626518
HMS3713H14
HY-B0876
I11-0350
KB-308082
KB-39957
KS-000001GS
KSC377C7J
Lopac-M-1387
Lopac0_000723
LS-128524
LS20097
M0774
MCULE-2732751720
MFCD00005245
MFCD00005245 (97+%)
MLS001335923
MolPort-016-633-159
NCGC00015646-01
NCGC00015646-02
NCGC00015646-03
NCGC00015646-04
NCGC00162231-01
NSC-760365
NSC760365
Pharmakon1600-01506159
PubChem13055
PYRAZOLE, 4-METHYL-
Q-101886
RIKMMFOAQPJVMX-UHFFFAOYSA-N
RTR-037683
s137
S14-0570
s1717
SBB004402
SBI-0050701.P002
SC-04749
SMR000059088
ST2411524
ST45123338
STK256626
SY006499
TL8005172
TR-037683
TRA0026533
UNII-83LCM6L2BY
VP20110
Z969563038
ZB015137
ZINC897288
zlchem 884
ZLD0345

US Patents and Regulatory Information for ANTIZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc ANTIZOL fomepizole INJECTABLE;INJECTION 020696-001 Dec 4, 1997 DISCN Yes No   See Pricing   See Pricing Y Y   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Boehringer Ingelheim
Medtronic
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.